AU2019900621A0 - Cells, compositions and methods for enhancing immune function - Google Patents

Cells, compositions and methods for enhancing immune function

Info

Publication number
AU2019900621A0
AU2019900621A0 AU2019900621A AU2019900621A AU2019900621A0 AU 2019900621 A0 AU2019900621 A0 AU 2019900621A0 AU 2019900621 A AU2019900621 A AU 2019900621A AU 2019900621 A AU2019900621 A AU 2019900621A AU 2019900621 A0 AU2019900621 A0 AU 2019900621A0
Authority
AU
Australia
Prior art keywords
compositions
cells
methods
immune function
enhancing immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019900621A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Publication of AU2019900621A0 publication Critical patent/AU2019900621A0/en
Priority to CN202080031702.XA priority Critical patent/CN113905747A/en
Priority to EP20762571.6A priority patent/EP3930732A4/en
Priority to US17/434,486 priority patent/US20220135642A1/en
Priority to MX2021010274A priority patent/MX2021010274A/en
Priority to SG11202109086XA priority patent/SG11202109086XA/en
Priority to CA3131541A priority patent/CA3131541A1/en
Priority to PCT/AU2020/050176 priority patent/WO2020172715A1/en
Priority to AU2020229478A priority patent/AU2020229478A1/en
Priority to JP2021549522A priority patent/JP2022521541A/en
Priority to KR1020217030956A priority patent/KR20210143779A/en
Priority to BR112021017057A priority patent/BR112021017057A2/en
Priority to IL285881A priority patent/IL285881A/en
Abandoned legal-status Critical Current

Links

AU2019900621A 2019-02-27 2019-02-27 Cells, compositions and methods for enhancing immune function Abandoned AU2019900621A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BR112021017057A BR112021017057A2 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
SG11202109086XA SG11202109086XA (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
EP20762571.6A EP3930732A4 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
US17/434,486 US20220135642A1 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
MX2021010274A MX2021010274A (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function.
CN202080031702.XA CN113905747A (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
CA3131541A CA3131541A1 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
PCT/AU2020/050176 WO2020172715A1 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
AU2020229478A AU2020229478A1 (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
JP2021549522A JP2022521541A (en) 2019-02-27 2020-02-27 Cells, compositions, and methods for enhancing immune function
KR1020217030956A KR20210143779A (en) 2019-02-27 2020-02-27 Cells, compositions and methods for enhancing immune function
IL285881A IL285881A (en) 2019-02-27 2021-08-25 Cells, compositions and methods for enhancing immune function

Publications (1)

Publication Number Publication Date
AU2019900621A0 true AU2019900621A0 (en) 2019-03-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3917927A4 (en) Immunomodulators, compositions and methods thereof
EP3774750A4 (en) Immunomodulators, compositions and methods thereof
EP3665156A4 (en) Compounds, compositions and methods
WO2018109170A3 (en) Il-11ra antibodies
EP3923935A4 (en) Compounds, compositions and methods
WO2018109174A3 (en) Il-11 antibodies
EP3924341A4 (en) Compounds, compositions and methods
EP3868399A4 (en) Immune composition, preparation method therefor, and application thereof
EP3884065A4 (en) Direct-to-library methods, systems, and compositions
EP3946439A4 (en) Compositions and methods for preparing t cell compositions and uses thereof
EP3911355A4 (en) Recombinant lubricins, and compositions and methods for using the same
GB202017595D0 (en) Compositions, and methods and uses relating thereto
GB201901099D0 (en) Methods, uses and compositions
EP3917546A4 (en) Gene-regulating compositions and methods for improved immunotherapy
EP3962955A4 (en) Antigen specific cd19-targeted car-t cells
EP3773520A4 (en) Bioxomes particles, redoxomes, method and composition
IL287120A (en) Compounds, compositions and methods
EP3760633A4 (en) Oxazino-quinazoline and oxazino-quinazoline type compound, preparation method therefor, and uses thereof
EP3931216A4 (en) Engineered immune cells
EP3930732A4 (en) Cells, compositions and methods for enhancing immune function
EP4007586A4 (en) Cells for improved immunotherapy and uses thereof
EP3897706A4 (en) Compositions, methods and uses for eliciting an immune response
EP3917320A4 (en) Bacterialcidal methods and compositions
EP3943932A4 (en) Method for providing immune cells
AU2019900621A0 (en) Cells, compositions and methods for enhancing immune function